524711 VISTAPH

Vista Pharmaceuticals Share Price

₹10.20 0.00 (0.00%)

23 Jan, 2025 01:22

SIP TrendupStart SIP in VISTAPH

Start SIP

Performance

  • Low
  • ₹0
  • High
  • ₹0
  • 52 Week Low
  • ₹0
  • 52 Week High
  • ₹0
  • Open Price₹0
  • Previous Close₹0
  • Volume0

Investment Returns

  • Over 1 Month -12.37%
  • Over 3 Month -17.07%
  • Over 6 Month -29.41%
  • Over 1 Year -37.19%
SIP Lightning

Smart Investing Starts Here Start SIP with Vista Pharmaceuticals for Steady Growth!

Invest Now

Vista Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

Vista Pharmaceuticals Financials

Vista Pharmaceuticals Technicals

EMA & SMA

Current Price
₹10.20
0 (0%)
pointer
  • stock-down_img
  • Bearish Moving Average 16
  • stock-up_img
  • Bullish Moving Average 0
  • 20 Day
  • ₹10.83
  • 50 Day
  • ₹11.43
  • 100 Day
  • ₹12.03
  • 200 Day
  • ₹12.66

Resistance and Support

10.21 Pivot Speed
  • R3 11.55
  • R2 11.11
  • R1 10.65
  • S1 9.75
  • S2 9.31
  • S3 8.85

What's your outlook on Vista Pharmaceuticals?

You can only vote for once

Vista Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2024-11-13 Quarterly Results
2024-08-13 Quarterly Results
2024-05-28 Audited Results
2024-02-10 Quarterly Results
2023-11-10 Quarterly Results

Vista Pharmaceuticals F&O

Vista Pharmaceuticals Shareholding Pattern

No data available.

About Vista Pharmaceuticals

  • NSE Symbol
  • VISTAPH
  • BSE Symbol
  • 524711
  • ISIN
  • INE427C01021

Similar Stocks to Vista Pharmaceuticals

Vista Pharmaceuticals FAQs

Vista Pharmaceuticals share price is ₹10 As on 23 January, 2025 | 01:08

The Market Cap of Vista Pharmaceuticals is ₹46.5 Cr As on 23 January, 2025 | 01:08

The P/E ratio of Vista Pharmaceuticals is -13.8 As on 23 January, 2025 | 01:08

The PB ratio of Vista Pharmaceuticals is 1.2 As on 23 January, 2025 | 01:08

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23